Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
23539 | 287 | 37.5 | 81% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1761 | 5878 | DIABETIC NEUROPATHY//SYMPATHETIC SKIN RESPONSE//NERVE BLOOD FLOW |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PROINSULIN C PEPTIDE | Author keyword | 30 | 84% | 6% | 16 |
2 | C PEPTIDE | Author keyword | 18 | 14% | 40% | 116 |
3 | HUMAN C PEPTIDE | Author keyword | 8 | 100% | 2% | 5 |
4 | SECT CLIN PHYSIOL | Address | 7 | 28% | 7% | 21 |
5 | UP EA 21 93 | Address | 3 | 60% | 1% | 3 |
6 | DIABETES TYPES 1 AND 2 | Author keyword | 2 | 67% | 1% | 2 |
7 | C PEPTIDE RECEPTOR | Author keyword | 1 | 100% | 1% | 2 |
8 | GPR146 | Author keyword | 1 | 100% | 1% | 2 |
9 | INSULIN DISAGGREGATION | Author keyword | 1 | 100% | 1% | 2 |
10 | PEPTIDE DEPOSITS | Author keyword | 1 | 100% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PROINSULIN C PEPTIDE | 30 | 84% | 6% | 16 | Search PROINSULIN+C+PEPTIDE | Search PROINSULIN+C+PEPTIDE |
2 | C PEPTIDE | 18 | 14% | 40% | 116 | Search C+PEPTIDE | Search C+PEPTIDE |
3 | HUMAN C PEPTIDE | 8 | 100% | 2% | 5 | Search HUMAN+C+PEPTIDE | Search HUMAN+C+PEPTIDE |
4 | DIABETES TYPES 1 AND 2 | 2 | 67% | 1% | 2 | Search DIABETES+TYPES+1+AND+2 | Search DIABETES+TYPES+1+AND+2 |
5 | C PEPTIDE RECEPTOR | 1 | 100% | 1% | 2 | Search C+PEPTIDE+RECEPTOR | Search C+PEPTIDE+RECEPTOR |
6 | GPR146 | 1 | 100% | 1% | 2 | Search GPR146 | Search GPR146 |
7 | INSULIN DISAGGREGATION | 1 | 100% | 1% | 2 | Search INSULIN+DISAGGREGATION | Search INSULIN+DISAGGREGATION |
8 | PEPTIDE DEPOSITS | 1 | 100% | 1% | 2 | Search PEPTIDE+DEPOSITS | Search PEPTIDE+DEPOSITS |
9 | ACTIVATING TRANSCRIPTION FACTOR ATF | 1 | 50% | 0% | 1 | Search ACTIVATING+TRANSCRIPTION+FACTOR+ATF | Search ACTIVATING+TRANSCRIPTION+FACTOR+ATF |
10 | C PEPTIDE BINDING | 1 | 50% | 0% | 1 | Search C+PEPTIDE+BINDING | Search C+PEPTIDE+BINDING |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HUMAN CELL MEMBRANES | 44 | 100% | 6% | 16 |
2 | STIMULATE GLUCOSE UTILIZATION | 8 | 100% | 2% | 5 |
3 | RENAL TUBULAR CELLS | 2 | 15% | 5% | 15 |
4 | ERYTHROCYTE NA | 2 | 67% | 1% | 2 |
5 | EXERCISING FOREARM | 1 | 100% | 1% | 2 |
6 | O 2 INDUCED ATP RELEASE | 1 | 100% | 1% | 2 |
7 | PROSURFACTANT PROTEIN C | 1 | 40% | 1% | 2 |
8 | PROINSULIN C PEPTIDE | 1 | 16% | 2% | 5 |
9 | INSULIN RESISTANT STATE | 1 | 50% | 0% | 1 |
10 | BRACHIAL REACTIVITY | 0 | 33% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
C-peptide: New findings and therapeutic possibilities | 2015 | 1 | 61 | 80% |
The Physiology of Proinsulin C-Peptide: Unanswered Questions and a Proposed Model | 2015 | 1 | 51 | 73% |
Cellular and physiological effects of C-peptide | 2009 | 30 | 71 | 75% |
Physiological effects and therapeutic potential of proinsulin C-peptide | 2014 | 3 | 106 | 64% |
C-Peptide as a Therapeutic Tool in Diabetic Nephropathy | 2010 | 22 | 49 | 63% |
C-peptide replacement therapy as an emerging strategy for preventing diabetic vasculopathy | 2014 | 2 | 118 | 56% |
Intracellular Signalling by C-Peptide | 2008 | 18 | 56 | 68% |
C-peptide and long-term complications of diabetes | 2011 | 11 | 106 | 53% |
C-peptide: new findings and therapeutic implications in diabetes | 2004 | 32 | 62 | 71% |
C-Peptide: A New Mediator of Atherosclerosis in Diabetes | 2012 | 6 | 56 | 63% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SECT CLIN PHYSIOL | 7 | 28% | 7.3% | 21 |
2 | UP EA 21 93 | 3 | 60% | 1.0% | 3 |
3 | PHARMACOL A | 1 | 40% | 0.7% | 2 |
4 | MORRIS HOOD JR COMPREHENS DIABET | 1 | 20% | 1.4% | 4 |
5 | BERGMANNSHEIL TRAUMA | 1 | 50% | 0.3% | 1 |
6 | CARDIOVASC NETWORK | 1 | 50% | 0.3% | 1 |
7 | CRIT CARE MEDCINCINNATI CHILDRENS HOSP MED C | 1 | 50% | 0.3% | 1 |
8 | ENDOCRINE DIS UNIT | 1 | 50% | 0.3% | 1 |
9 | MOL BIYOLOJI ANABILIM DALI | 1 | 50% | 0.3% | 1 |
10 | NUTR ENDOCRINOL MALAD METAB | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000129061 | C PEPTICLE//CLIN PHYSIOL METAB UNIT//HENRY WELLCOME S EGRATED CELL SIGNALLING |
2 | 0.0000124527 | DIABETIC NEUROPATHY//NERVE BLOOD FLOW//VASA NERVORUM |
3 | 0.0000092745 | GLIMEPIRIDE//JTT 608//SECONDARY FAILURE |
4 | 0.0000079731 | EXPT BIOTECHNOL PLANT//HUMAN CONSENSUS INTERFERON ALPHA//A21 DESAMIDOINSULIN |
5 | 0.0000069614 | CNRS BIOCHIM THEOR//AUTOSTEREOGRAM//TRANSFORMATION OF DATA |
6 | 0.0000066621 | PROINSULIN//INTACT PROINSULIN//SPLIT PROINSULIN |
7 | 0.0000062310 | INSULIN GENE THERAPY//DIABETES GENE THERAPY//ENDOCRINOL METAB SECT 111 |
8 | 0.0000060158 | MONOMERIC INSULIN//INSULIN MUTANT//SINGLE CHAIN INSULIN |
9 | 0.0000051673 | ROCKIES FDN//EXERCISE HYPEREMIA//HUMAN CARDIOVASC PHYSIOL |
10 | 0.0000045763 | METABOLIC MEMORY//HYPERGLYCEMIC MEMORY//EPIGEN PROFILING IL |